Open Access

Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer

  • Authors:
    • Qiuning Zhang
    • Zhitong Bing
    • Jinhui Tian
    • Xiaohu Wang
    • Ruifeng Liu
    • Yi Li
    • Yarong Kong
    • Yan Yang
  • View Affiliations

  • Published online on: April 10, 2019     https://doi.org/10.3892/ol.2019.10240
  • Pages: 5377-5388
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Oesophageal cancer is a serious disease worldwide. In China, the incidence of esophageal cancer was reported to be ~478,000 in 2015. In the same year, the incidence of esophageal cancer in the United States was ~16,910. Radiotherapy serves as an important tool in the treatment of oesophageal cancer, and although radiation therapy has progressed over time, the prognosis of the majority of patients with oesophageal cancer remains poor. Additionally, the sensitivity of patients with oesophageal cancer to radiotherapy and chemotherapy is not yet clear. Although there are a number of studies on the radiosensitivity of oesophageal cancer cell lines, the vastly different results from different cell lines make them unreliable to use as a guide in clinical practice. Therefore, a common radiosensitive gene signature may provide more reliable results, and using different combinations of common gene signatures to predict the outcome of patients with oesophageal cancer may generate a unique gene signature in oesophageal cancer. In the present study, the radiosensitive index and prognostic index were calculated to predict clinical outcomes. The prognostic index of a 41‑gene signature combination is the largest combination of gene signatures used for classifying oesophageal cancer patients into radiosensitive (RS) and radioresistance (RR) groups, to the best of our knowledge, and this gene signature was more effective in patients classified as having Stage III oesophageal cancer. Furthermore, four genes (carbonyl reductase 1, serine/threonine kinase PAK2, ras‑related protein Rab 13 and twinfilin‑1) may be sufficient to classify patients into either RS or RR. Subsequent to gene enrichment analysis, the cell communication pathway was significantly different between RS and RR groups in oesophageal cancer. These results may provide useful insights in improving radiotherapy strategies in clinical decisions.
View Figures
View References

Related Articles

Journal Cover

June-2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Q, Bing Z, Tian J, Wang X, Liu R, Li Y, Kong Y and Yang Y: Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer. Oncol Lett 17: 5377-5388, 2019.
APA
Zhang, Q., Bing, Z., Tian, J., Wang, X., Liu, R., Li, Y. ... Yang, Y. (2019). Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer. Oncology Letters, 17, 5377-5388. https://doi.org/10.3892/ol.2019.10240
MLA
Zhang, Q., Bing, Z., Tian, J., Wang, X., Liu, R., Li, Y., Kong, Y., Yang, Y."Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer". Oncology Letters 17.6 (2019): 5377-5388.
Chicago
Zhang, Q., Bing, Z., Tian, J., Wang, X., Liu, R., Li, Y., Kong, Y., Yang, Y."Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer". Oncology Letters 17, no. 6 (2019): 5377-5388. https://doi.org/10.3892/ol.2019.10240